Cisplatin can be safely administered to ovarian cancer patients with hypersensitivity to carboplatin

Autor: Bergamini, A., Pisano, C., Di Napoli, M., Arenare, L., Della Pepa, C., Tambaro, R., Facchini, G., Gargiulo, P., Rossetti, S., Mangili, G., Pignata, S., Cecere, S.C.
Zdroj: In Gynecologic Oncology January 2017 144(1):72-76
Databáze: ScienceDirect